Grateful to see our recent publication on KINASERA® 750,000 IU (Streptokinase) reaching a wider…
At RIHCA / RAWIA INTERNATIONAL HEALTHCARE, we remain committed to supporting healthcare professionals and institutions with reliable…
Grateful to see our recent publication on KINASERA® 750,000 IU (Streptokinase) reaching a wider professional audience on LinkedIn.
At RIHCA / RAWIA INTERNATIONAL HEALTHCARE, we remain committed to supporting healthcare professionals and institutions with reliable thrombolytic solutions that play a critical role in emergency cardiovascular care.
KINASERA® 750,000 IU continues to support physicians and critical care teams in managing acute thrombotic conditions where timely intervention is essential.
Every step toward sharing knowledge and advancing access to life-saving treatments strengthens our mission.
To Share • To Care • To Inspire.
KINASERA #Streptokinase #750000IU #ThrombolyticTherapy #EmergencyMedicine #CardiovascularCare #CriticalCare #RAWIACARE #RIHCA
메타데이터
- post_id
- 94dab47972c2
- slug
- grateful-to-see-our-recent-publication-on-kinasera-750-000-iu-streptokinase-reaching-a-wider-94dab47972c2
- url
- https://medium.com/@sales_79177/grateful-to-see-our-recent-publication-on-kinasera-750-000-iu-streptokinase-reaching-a-wider-94dab47972c2
- canonical_url
- https://medium.com/@sales_79177/grateful-to-see-our-recent-publication-on-kinasera-750-000-iu-streptokinase-reaching-a-wider-94dab47972c2
- author_url
- https://medium.com/@sales_79177
- status
- ok
- fetched_at
- 2026-06-09 15:37:30
